Safe Injection Facilities

Decent Essays
Individuals who exclusively use Insite as their drug injection site are seven times less likely to share drug related paraphernalia, such as syringes, which then decreases the risk of transmitting injection related diseases, such as Hepatitis C Vitus (HCV) to others (Kerr et al., 2005a). North America’s first safe injection facility, Insite, was developed in the Downtown Eastside of Vancouver, British Columbia, in 2003. Insite was developed as a way to research the effect levels of prevention, treatment, and crime (Macdonald, 2011). Based on the scientific inquiry gathered since the opening of Insite, Canada should create more safe injection sites across the country. This paper discusses how the development of safe injection facilities will…show more content…
In March 2004, an 18-month study was developed to calculate the number of overdose events that occurred at Insite that could have been resulted to drug related complications, including death (Kerr et al., 2006a). Within the 18 months of the study, there was a total of 336 overdose events, a rate of 133 overdose events per 10000 injections at Insite (Kerr et al., 2006a). “None of the overdose events occurring at the [safe injection facility] resulted in a fatality” (Kerr et al., 2006a, p4). Insite has trained health professionals who are able to recognize the indicators of injection drug related overdose, such as ace turning pale, blue, or flushed, or not being able to respond to pain stimulus (Kerr et al., 2006a). Due to prior knowledge, the health professionals are able to take the appropriate measures to stabilize the injection drug user, which will decrease the injection drug related overdose fatality rate (Kerr et al., 2006a). Blood borne diseases, such as HVC and the Human Immunodeficiency Virus (HIV), are deadly diseases that are commonly found in injection drug users (REFERENCE). Injection drug users are high at risk for these deadly diseases due to the fact that many injection drug users tend to share paraphernalia, like syringes, which can also transmit blood to and from the injection drug user (Kerr et al., 2005a), (Kerr et al., 2005b). Another study was conducted in March 2004 for a 7-month period to examine if the safe injection site reduced syringe sharing amongst injection drug users who use Insite (Kerr et al., 2005b). 582 individuals were analyzed for HIV, and were asked to state whether or not they had been sharing syringes in the past (Kerr et al., 2005b). The results of the
Get Access